Percutaneous revascularization for unstable angina in the elderly

Coronary Artery Disease

Volumn 11, Issue 4, 2000, Pages 315-322

  Hirsch, Herbert ^b   Lazar, Jason ^b   Marzo, Kevin P ^b   Steingart, Richard M ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

Acute coronary syndromes; Elderly; Percutaneous coronary intervention

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; NITRATE; TICLOPIDINE;

ADULT; AGED; BLEEDING; CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; GERIATRIC SURGERY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; ASPIRIN; CORONARY ARTERY BYPASS; HEPARIN; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; SURVIVAL ANALYSIS; SYNDROME; TREATMENT OUTCOME;

EID: 0034047374     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200006000-00004     Document Type: Review

References (52)

1. 1 Braunwald E, Mark DB, Jones RH, Cheitlin MD, Fuster V, McCauley KM, et al. Unstable angina: diagnosis and management. Rockville, MD: Agency for Health Care Policy and Research and the National Heart, Lung and Blood Institute, Public Health Service, USA Department of Health and Humans Services; 1994. AHCPR guidelines for the management of unstable angina. This is the definitive reference source but an update is in progress.
2. 2 Braunwald E. Unstable angina: a classification. Circulation 1989; 80:410-414.
3. 3 Antman E, Tanasijevic M, Thompson B, Schactman M, McCabe C, Cannon C, et al. Cardiac-specific troponin levels to predict the risk of mortality in patients with acute coronary syndrome. N Engl J Med 1996; 336:1342-1349.
4. 4 Glavani M, Ottani F, Ferrini D, Ladenson J, Destro A, Baccos D, et al. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. Circulation 1997; 95:2053-2059.
5. 5 Olson H, Aronow W. Medical management of stable angina and unstable angina in the elderly with coronary artery disease. Clin Geriatr Med 1996; 12:121-140.
6. 6 Anderson HV, Gibson RS, Stone PH, Cannon CP, Aguirre F, Thompson B, et al. for the TIMI III Registry Study Group. Management of unstable angina pectoris and non-Q-wave acute myocardial infarction in the United States and Canada (The TIMI III Registry). Am J Cardiol 1997; 79:1441-1446. This is a large registry experience with unstable angina in the elderly.
7. 7 Ambrose J, Hjemdahl-Monsen C, Borrico S, Gorlin R, Fuster V. Angiographic demonstration of a common link between unstable angina pectoris and non-O-wave acute myocardial infarction. Am J Cardiol 1988; 61:244-247.
8. 8 Ambrose J. Plaque disruption and the acute coronary syndromes of unstable angina and myocardial infarction: if the substrate is similar, why is the clinical presentation different? J Am Coll Cardiol 1992; 19:1653-1658.
9. 9 Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Circulation 1985; 71:699-708.
10. 10 Paul SD, O'Gara PT, Mahjoub ZA, DiSalvo TG, O'Donnell CJ, Newell JB, et al. Geriatric patients with acute myocardial infarction: cardiac risk profiles, presentation, thrombolysis, coronary interventions and prognosis. Am Heart J 1996; 131:710-715.
11. 11 The RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 1990; 336:827-830.
12. 12 Cairns JA, Gent M, Singer J, Finnie K, Groggatt G, Holder DA, et al. Aspirin, sulfinpyrazone, or both in unstable angina. N Engl J Med 1985; 313:1369-1375.
13. 13 Lewis HD, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Engl J Med 1983; 309:396-403.
14. 14 Theroux P, Ouimet H, McCans J, Latour J, Joly P, Levy G, et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 1988; 319:1105-1111. Classic paper on therapy.
15. 15 Antiplatelet Trialists Collaboration. Collaborative overview of randomized trials of antiplatelet therapy - I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 208:81-106. An exhaustive meta-analysis of therapy to date.
16. 16 Balsano F, Rizzon P, Violi P, Scrutinio O, Cimminiello C, Aguglia F, et al. Antiplatelet treatment with ticopidine in unstable angina: a controlled multicenter trial. Circulation 1990; 82:17-26.
17. 17 Theroux P, Waters D, Qiu S, McCans J, deGuise P, Juneau M. Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina. Circulation 1993; 88:2045-2048.
18. 18 Holdright D, Patel D, Cunningham D, Thomas R, Hubbard W, Hendry G, et al. Comparison of the effect of heparin and aspirin versus aspirin alone on transient myocardial ischemia and in-hospital prognosis in patients with unstable angina. J Am Coll Cardiol 1994; 24:39-45.
19. 19 GUSTO IIb Investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndrome. N Engl J Med 1996; 335:775-782.
20. 20 Cohen M, Demers C, Gurfinkel E, Turpie A, Fromell G, Goodman S, et al. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med 1997; 337:447-452.
21. 21 Klein W, Buchwald A, Hillis S, Monrad S, Sanz G, Turpic AGG, et al. Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Circulation 1997; 96:61-68.
22. 22 The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Circulation 1994; 89:1545-1556. A large representation of the elderly in a randomized controlled trial.
23. 23 NYS Department of Health. Coronary angioplasty reports 1995. Albany: New York State Department of Health; 1995.
24. 24 Bedotto JB, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV, Shimshak TM, et al. Results of multivessel percutaneous transluminal coronary angioplasty in persons age 65 years and older. Am J Cardiol 1991; 67:1051-1055.
25. 25 Kelsey SF, Miller DP, Holubkov R, Lu AS, Cowley MJ, Faxon DP, et al. Results of percutaneous transluminal coronary angioplasty in patients greater than or equal to 65 years of age (from the 1985 to 1986 National Heart, Lung and Blood Institute's Coronary Angioplasty Registry). Am J Cardiol 1990; 66:1033-1038.
26. 26 Thompson RC, Holmes DR, Grill DE, Mock MB, Bailey KR. Changing outcome of angioplasty in the elderly. J Am Coll Cardiol 1996; 27:8-14.
27. 27 Guadagnoli E, Ayanian JZ, Cleary PD. Comparison of patient-reported outcomes after elective coronary artery bypass grafting in patients aged ≥ 65 years. Am J Cardiol 1992; 70:60-64.
28. 28 The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996; 335:217-225.
29. 29 Vacek JL, Rosamond TL, Kramer PH, Crouse LJ, Porter CB, Robuck OW, et al. Sex-related differences in patients undergoing angioplasty for acute myocardial infarction. Am Heart J 1993; 126:521-525.
30. 30 Welty FK, Mittleman MA, Healy RW, Muller JE, Shubrooks SJ Jr. Similar results of percutaneous transluminal coronary angioplasty in women compared with men. J Am Coll Cardiol 1994; 24:81-90.
31. 31 Safford RE. Coronary revascularization in the elderly: Florida Multicenter consecutive case experience with coronary revascularization in patients age 75 years and older. Comprehensive Ther 1996; 22:477-484.
32. 32 Mock MB, Holmes DR Jr, Vliestra RE, Gersh BJ. Percutaneous transluminal coronary angioplasty (PTCA) in the elderly patient: experience of the NHLBI PTCA Registry. Am J Cardiol 1984; 53:89c-91c.
33. 33 Imburgia M, King TR, Soffer A, Rich MW, Krom RJ, Salimi A. Early results and long term outcome of percutaneous transluminal coronary angioplasty in patients 75 years and older. Am J Cardiol 1989; 63:1127-1129.
34. 34 McGrath MA, Peet GI, Franke JG, Mildenberger RR, March JE, Mackenzie GW. PTCA in elderly patients: hospital events. Am J Crit Care 1993; 2:171-176.
35. 35 Morrison DA, Bies RD, Sacks J. Coronary angioplasty for elderly patients with 'high risk' unstable angina: short-term outcomes and long-term survival. J Am Coll Cardiol 1997; 29:339-344.
36. 36 Stone PH, Thompson B, Anderson HV, Kronenberg MW, Gibson RS, Rogers WJ, et al. for the TIMI III Registry Study Group. Influence of race, sex and age on the management of unstable angina and non-Q-wave myocardial infarction. The TIMI III Registry. JAMA 1996; 275:1104-1112. A detailed analysis of practice patterns for patients with unstable angina.
37. 37 Thompson RC, Holmes DR, Gersh BJ, Bailey KR. Predicting early and intermediate-term outcome of coronary angioplasty in the elderly. Circulation 1993; 88:1579-1587.
38. 38 Yusuf S, Flather M, Pogue JP, Hunt D, Varigos J, Pieggs L, et al. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. Lancet 1998; 352:507-514.
39. 39 Boden WE, O'Rourke RA, Crawford MH, Blaustein AS, Deedwania PC, Zoble RG, et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med 1998; 338:1785-1792.
40. 40 The CAPTURE Investigators. Randomized placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina. Lancet 1997; 349:1429-1435.
41. 41 The EPIC Investigators. Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994; 330:956-961.
42. 42 Lincoff AM, Califf RM, Anderson K, Weisman HF, Aguirre FV, Kleiman NS, et al. Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockage by abciximab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization. J Am Coll Cardiol 1997; 30:149-156.
43. 43 The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997; 336:1689-1696.
44. 44 Nasser TK, Fry ET, Annan K, Khatib Y, Peters TF, VanTassel J, et al. Comparison of six-month outcome of coronary artery stenting in patients < 65, 65-75, and > 75 years of age. Am J Cardiol 1997; 80:998-1001.
45. 45 Fraioli M, Gambino A, Heller LI, Steingart RM, Marzo KP. Peripheral vascular complications associated with Palmaz-Schatz coronary stenting in the elderly. Am J Geriatr Cardiol 1996; 5:60.
46. 46 Manzar K, Steingart RM, Gambino AT, Marzo KP. The use of platelet receptor IIb/IIIa antibody abciximab in elderly: does age affect outcome with this new agent? Am J Geriatr Cardiol 1997; 6:42.
47. 47 Cheitlin MD. Coronary bypass surgery in the elderly. Clin Geriatr Med 1996; 12:195-205.
48. 48 NYS Department of Health. Coronary artery bypass results 1995. Albany: New York State Department of Health; 1995.
49. 49 Luchi RJ, Scott SM, Deupree RH. Comparison of medical and surgical treatment for unstable angina pectoris. N Engl J Med 1987; 316:977-984.
50. 50 Hultgren HN, Pfeifer JF, Angell WW, Lipton MJ, Bilisoly J. Unstable angina: comparison of medical and surgical management. Am J Cardiol 1977; 39:734-740.
51. 51 Eggeling T, Holz W, Osterhues HH, Pohler G, Kochs M, Nombach V. Management of unstable angina in patients over 75 years old. Coronary Artery Dis 1995; 6:891-896.
52. 52 O'Keefe JH, Sutton MB, McCallister BD, Vacek JL, Piehler JM, Ligon RW, et al. Coronary angioplasty versus bypass surgery in patients > 70 years old matched for ventricular function. J Am Coll Cardiol 1994; 24:425-430.